1. Home
  2. RCKT vs MTW Comparison

RCKT vs MTW Comparison

Compare RCKT & MTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • MTW
  • Stock Information
  • Founded
  • RCKT 1999
  • MTW 1902
  • Country
  • RCKT United States
  • MTW United States
  • Employees
  • RCKT N/A
  • MTW N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • MTW Construction/Ag Equipment/Trucks
  • Sector
  • RCKT Health Care
  • MTW Industrials
  • Exchange
  • RCKT Nasdaq
  • MTW Nasdaq
  • Market Cap
  • RCKT 328.6M
  • MTW 358.5M
  • IPO Year
  • RCKT N/A
  • MTW N/A
  • Fundamental
  • Price
  • RCKT $3.28
  • MTW $9.89
  • Analyst Decision
  • RCKT Buy
  • MTW Hold
  • Analyst Count
  • RCKT 13
  • MTW 4
  • Target Price
  • RCKT $12.96
  • MTW $11.00
  • AVG Volume (30 Days)
  • RCKT 6.0M
  • MTW 381.2K
  • Earning Date
  • RCKT 08-07-2025
  • MTW 08-07-2025
  • Dividend Yield
  • RCKT N/A
  • MTW N/A
  • EPS Growth
  • RCKT N/A
  • MTW 436.41
  • EPS
  • RCKT N/A
  • MTW 1.26
  • Revenue
  • RCKT N/A
  • MTW $2,131,200,000.00
  • Revenue This Year
  • RCKT N/A
  • MTW N/A
  • Revenue Next Year
  • RCKT $108.43
  • MTW $4.66
  • P/E Ratio
  • RCKT N/A
  • MTW $7.86
  • Revenue Growth
  • RCKT N/A
  • MTW N/A
  • 52 Week Low
  • RCKT $2.19
  • MTW $7.06
  • 52 Week High
  • RCKT $22.01
  • MTW $13.62
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 51.17
  • MTW 38.48
  • Support Level
  • RCKT $2.88
  • MTW $9.91
  • Resistance Level
  • RCKT $3.74
  • MTW $10.19
  • Average True Range (ATR)
  • RCKT 0.27
  • MTW 0.35
  • MACD
  • RCKT 0.02
  • MTW 0.08
  • Stochastic Oscillator
  • RCKT 35.43
  • MTW 61.07

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About MTW Manitowoc Company Inc. (The)

Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.

Share on Social Networks: